Dr iur Reto Jacobs > Walder Wyss Ltd. > Zurich, Switzerland > Lawyer Profile
Walder Wyss Ltd. Offices
PO BOX 1236
- Go to...
Dr iur Reto Jacobs
Antitrust and Competition Team
Reto Jacobs heads the Antitrust and Competition Team. He advises domestic and foreign companies with respect to all competition law issues, represents them before competition authorities and courts, and assists them in complex merger filings. Reto Jacobs advises also with respect to distribution systems and he supports various companies with respect to their antitrust compliance programs. He is lecturer at the University of St. Gall.
Reto Jacobs speaks German, English and French.
Born in 1964, Reto Jacobs was educated at the University of St. Gall (lic. iur. 1990, Dr. iur. 1997). He obtained an additional degree in European competition law from the University of Amsterdam (LL.M. 1993) and stayed as visiting scholar at the University of California at Berkeley.
Lawyer Rankings(Leading individuals)
With a large team of highly proficient lawyers, Walder Wyss Ltd. is a go-to firm for all competition matters. The team handles merger control proceeding with skill and efficiency, advising both local and international companies with filings and complex transactions. The firm represents a vast and diverse array of clients in industries such as telecommunications, transport, energy, banking, and construction. Reto Jacobs has extensive experience setting up distribution and compliance systems. He leads the team with Monique Sturny who is a skilled negotiator, representing clients in competition proceedings.
Top Tier Firm Rankings
- Data privacy and data protection
- Intellectual property
- Leading firms: Italian-speaking Switzerland
- Private client
- Public law
- Real estate and construction
- Banking and finance: Zurich
- Capital markets
- Commercial, corporate and M&A
- Dispute resolution: arbitration
- Dispute resolution: litigation
- Leading firms: French-speaking Switzerland
- Leading firms: German-speaking Switzerland
- Banking and finance: Geneva
- Healthcare and life sciences
- Insolvency and corporate recovery